Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Association of metabolic syndrome with insulin-like growth factors among adults in the US.

Saydah S, Ballard-Barbash R, Potischman N.

Cancer Causes Control. 2009 Oct;20(8):1309-16. doi: 10.1007/s10552-009-9351-x.

PMID:
19415508
2.

Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.

Appel SJ, Harrell JS, Davenport ML.

J Am Acad Nurse Pract. 2005 Dec;17(12):535-41.

PMID:
16293162
3.

Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.

Boney CM, Verma A, Tucker R, Vohr BR.

Pediatrics. 2005 Mar;115(3):e290-6.

PMID:
15741354
4.

Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.

Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD.

Asia Pac J Clin Nutr. 2003;12(3):271-6.

6.
9.

Blood pressure control and components of the metabolic syndrome: the GOOD survey.

Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE.

Cardiovasc Diabetol. 2009 Sep 15;8:51. doi: 10.1186/1475-2840-8-51.

10.

[Leptin and clustering of the components of risk factors for metabolic syndrome].

Li M, Wu CY, Zhan ZW, Li XG, Zhang K, Xiang HD.

Zhonghua Yu Fang Yi Xue Za Zhi. 2004 Jul;38(4):226-30. Chinese.

PMID:
15312578
11.

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.

Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A, Hellénius ML, Fisher RM.

Eur Heart J. 2007 Nov;28(21):2637-43.

12.

Insulin-like growth factors and subsequent risk of mortality in the United States.

Saydah S, Graubard B, Ballard-Barbash R, Berrigan D.

Am J Epidemiol. 2007 Sep 1;166(5):518-26.

PMID:
17602136
13.

The influence of age and body mass index on the metabolic syndrome and its components.

Alexander CM, Landsman PB, Grundy SM.

Diabetes Obes Metab. 2008 Mar;10(3):246-50. doi: 10.1111/j.1463-1326.2006.00695.x.

PMID:
18269640
14.

Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V.

Metabolism. 2005 Apr;54(4):476-81.

PMID:
15798954
15.

Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women.

Esmaillzadeh A, Mirmiran P, Moeini SH, Azizi F.

Int J Cardiol. 2006 Apr 14;108(3):338-45.

PMID:
15963581
16.

Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.

Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M.

Food Nutr Bull. 2009 Jun;30(2):161-70.

PMID:
19689095
17.

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.

Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.

Int J Obes (Lond). 2007 Feb;31(2):213-20.

PMID:
16755284
18.

Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.

Yun JE, Sull JW, Lee HY, Park E, Kim S, Jo J, Lee SJ, Kim SY, Choi YJ, Jee SH, Huh KB.

Diabetes Metab Res Rev. 2009 Mar;25(3):259-65. doi: 10.1002/dmrr.946.

PMID:
19214966
19.

Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.

Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, Succurro E, Lauro R, Federici M, Perticone F.

Diabetes Care. 2005 Jan;28(1):120-5.

PMID:
15616244
20.
Items per page

Supplemental Content

Support Center